Incidence of Duchenne muscular dystrophy in New South Wales and Australian Capital Territory
- PMID: 7205898
- PMCID: PMC1048563
- DOI: 10.1136/jmg.17.4.245
Incidence of Duchenne muscular dystrophy in New South Wales and Australian Capital Territory
Abstract
A survey was conducted during 1977 to 1978 to determine the incidence of Duchenne muscular dystrophy in New South Wales and the Australian Capital Territory. Ninety-nine cases born between 1960 and 1971 were ascertained representing an incidence rate of 18.6 per 100 000 liveborn males. Over 60% of the ascertained males were isolated cases, and only 7% of affected males had an affected males relative in a previous generation in the female line. Categorisation of ascertained cases as either "theoretically preventable" or not shows that genetic counselling alone in the present circumstances is insufficient to reduce the incidence rate significantly.
Similar articles
-
Child neuromuscular disease in southern Norway. The prevalence and incidence of Duchenne muscular dystrophy.Acta Paediatr Scand. 1989 Jan;78(1):100-3. doi: 10.1111/j.1651-2227.1989.tb10894.x. Acta Paediatr Scand. 1989. PMID: 2784019
-
The incidence of Duchenne muscular dystrophy in the South East of Scotland.Clin Genet. 1977 Apr;11(4):290-4. doi: 10.1111/j.1399-0004.1977.tb01315.x. Clin Genet. 1977. PMID: 856509
-
Incidence of Duchenne muscular dystrophy in the modern era; an Australian study.Eur J Hum Genet. 2022 Dec;30(12):1398-1404. doi: 10.1038/s41431-022-01138-2. Epub 2022 Jun 27. Eur J Hum Genet. 2022. PMID: 35754057 Free PMC article.
-
Molecular analysis and diagnosis of Duchenne muscular dystrophy.J R Coll Physicians Lond. 1988 Apr;22(2):65-7. J R Coll Physicians Lond. 1988. PMID: 3294388 Free PMC article. Review. No abstract available.
-
[Genetic epidemiology and prophylaxis of Duchenne type muscular dystrophy].Nihon Rinsho. 1982;40(7):1528-33. Nihon Rinsho. 1982. PMID: 6757480 Review. Japanese. No abstract available.
Cited by
-
Efficacy of Prednisolone in Generated Myotubes Derived From Fibroblasts of Duchenne Muscular Dystrophy Patients.Front Pharmacol. 2018 Dec 3;9:1402. doi: 10.3389/fphar.2018.01402. eCollection 2018. Front Pharmacol. 2018. PMID: 30559667 Free PMC article.
-
Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.ILAR J. 2014;55(1):119-49. doi: 10.1093/ilar/ilu011. ILAR J. 2014. PMID: 24936034 Free PMC article. Review.
-
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.Mamm Genome. 2012 Feb;23(1-2):85-108. doi: 10.1007/s00335-011-9382-y. Epub 2012 Jan 5. Mamm Genome. 2012. PMID: 22218699 Free PMC article. Review.
-
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.Orphanet J Rare Dis. 2020 Jun 5;15(1):141. doi: 10.1186/s13023-020-01430-8. Orphanet J Rare Dis. 2020. PMID: 32503598 Free PMC article.
-
Respiratory dysfunction in unsedated dogs with golden retriever muscular dystrophy.Neuromuscul Disord. 2014 Jan;24(1):63-73. doi: 10.1016/j.nmd.2013.10.001. Epub 2013 Oct 24. Neuromuscul Disord. 2014. PMID: 24295812 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical